AKUMIN INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On August 12, 2022, Akumin Inc. (the "Company") announced the termination of
employment of its Chief Financial Officer, William Larkin, and its Chief Legal
Officer and Corporate Secretary, Matthew Cameron, effective August 12, 2022.

On August 12, 2022, the Company also announced the appointment of David
Kretschmer, 63, as Interim Chief Financial Officer, effective August 12, 2022.
Prior to joining the Company, from February 2019 to August 2022, Mr. Kretschmer served as an independent consultant for a number of companies. From January 2018
until April 2018, Mr. Kretschmer served as interim CFO for Surgery Partners,
Inc. (NASDAQ: SGRY), a multi-specialty ambulatory surgical center company with
$2.5 billion of revenues. From April 2018 to February 2019, Mr. Kretschmer served as executive vice president of strategy and transformation of Surgery
Partners, Inc. Prior to that, Mr. Kretschmer spent 26 years with Anthem, Inc.
renamed Elevance Health, Inc. (Nasdaq: ELV), a health insurance provider with
more than $130 billion of revenues, where he most recently served as senior vice
president, treasurer and CIO and held various other positions of increasing
responsibility beginning in 1991. Prior to his time at Anthem, Mr. Kretschmer held a variety of financial management and corporate finance roles. Mr. Kretschmer received his B.S. in Business from the George Washington
University and his M.B.A. from the University in Chicago.

In connection with his appointment as Interim Chief Financial Officer, Mr. Kretschmer will receive the following compensation:

  •   Annual base salary of $450,000.



    •     Eligibility in the Company's cash Management Incentive Plan (MIP), with
          an incentive target bonus commensurate with other senior management MIP
          targets.



    •     Eligibility to receive Long Term Incentive Plan grants, which are
          expected to be granted by way of restricted stock units.



  •   Eligibility in the Company's standard benefits program.

In addition, Mr. Kretschmer will enter into the Company's standard
confidentiality and non-solicitation agreement.

The description above is qualified in its entirety by reference to the full and
complete terms of the Offer Letter to Mr. Kretschmer, dated August 12, 2022, a
copy of which is filed as Exhibit 10.1 hereto.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.       Description

10.1                Offer Letter, dated August 12, 2022

99.1                Press Release, dated August 12, 2022

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------